TORONTO, ON – December 17, 2024 – The Canadian Nuclear Isotope Council (CNIC) has, since its establishment in 2018, aimed to foster innovation within Canada’s isotope sector. This innovation has led Canada’s isotope industry to significant growth in recent years,
TORONTO, ON – December 4, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce that Projects Pivot, an Ontario-based project management company, has joined as its newest member organization. Projects Pivot was founded in 2016 by Barbara
TORONTO, ON – November 19, 2024 – The Canadian Nuclear Isotope Council (CNIC) is excited to announce that CUP Contract Labs, a German company offering contract laboratory services to clients across the radiopharmaceutical sector, has joined the CNIC as its
TORONTO, ON – November 15, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Telix Pharmaceuticals, an international biopharmaceutical company, as its newest member organization. Telix Pharmaceuticals (“Telix”) is a commercial-stage biotechnology company producing therapeutic and diagnostic
TORONTO, ON – November 12, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce that SAGE Engineering Services Ltd. has joined its growing network of leading Canadian supply chain companies. SAGE, an engineering firm established in 2000,
Toronto, Ontario – October 23, 2024 – Yesterday, the Government of Ontario released Ontario’s Affordable Energy Future: The Pressing Case for More Power, which details the province’s rising energy demands and the government’s path to proactively managing this demand. The report
TORONTO, ON — Following months of advocacy from the Canadian Nuclear Isotope Council (CNIC) and its industry partners, the Government of Ontario formally recognized the province’s leadership in the global nuclear isotope sector in today’s Phase 2 update to the
TORONTO, ON — September 9, 2024 – James Scongack, Chair of the Canadian Nuclear Isotope Council (CNIC), was awarded the King Charles III Coronation Medal last week, in recognition of his significant contributions to Ontario and Canada. In his role
Toronto – August 14, 2024 – With membership across the isotope supply chain, healthcare sector, and academic institutions, the Canadian Nuclear Isotope Council (CNIC) is committed to ensuring that the Canadian medical isotope industry is staffed with sufficient talent with
Toronto – August 7, 2024 – As part of its mission to ensure patients across Canada have access to the highest standard of medical care and nuclear medicine services, the Canadian Nuclear Isotope Council (CNIC) is proud to announce its
Toronto – July 16 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Agescan International Inc. (Agescan), bringing expertise in medical radiation shielding and strengthening the CNIC’s commitment to innovation and safety in the isotope industry. With
Toronto, June 10, 2024 – Last week, the Canadian Nuclear Isotope Council (CNIC) celebrated the successful conclusion of the 2024 Canadian Radiotheranostics Leaders’ Summit, held on June 6-7 at the MaRS Discovery District in Toronto. The event was delivered in